Liane's mention of capacity opens the door for me to do a little of the soft pumping that OPC always appreciates.;o)

AL:

"In the meantime, we are preparing for commercial readiness. The first of the new commercial filling and packaging machines that will be used with the AFREZZA installation system was delivered to our Danbury, Connecticut factory in August. We are in the process of qualifying that equipment, which has been in development for over a year.

This new system is something to behold. It is fully automated and truly amazing. This is huge, about 85 feet long. The input is Technosphere insulin powder, dose cups, cartridge covers and the packaging materials. The output is finished boxes of 90 cartridges that should be suitable for one month of therapy for most patients. The automation includes inspection and weighing of each cartridge and any cartridges bailing inspection are replaced by the robot.

This system produces cartridges at the rate of 400 per minute. Fifteen completed cartridges are sealed individually in a blister package, two of these are sealed in the foiled bag and three bags plus two inhalers and the package insert are placed in the box. Three of the commercial systems that launch will be sufficient to serve about 400,000 patients.

When the Danbury plant is fully equipped, the capacity is expected to be sufficient to serve about 2 million people. At the price of current rapid acting insulin analogs of equivalent dose, this capacity would potentially generate overall revenues of close to $4 billion."

http://seekingalpha.com/article/233332-mannkind-ceo-discusses-q3-2010-results-earnings-call-transcript?find=machines&all=false